The BT Test, or Biomarker Translation Test, is a blood test marketed by Provista Life Sciences for the early detection of breast cancer. The test can detect breast cancer-related proteins in the blood and, in conjunction with mammograms, can sometimes assist physicians in detecting breast cancer in women who have a high risk of breast cancer, or those with dense breast tissue that can make mammography difficult. Provista announced this week that it will file private insurance claims on behalf of women who take the test, in addition to covering the remainder of the cost not covered by insurance. Those who do not want to submit an insurance claim can get the test done for $295.
Posts Tagged ‘BT Test’
March 5, 2009


Dr. Steven Chang, the author of DailyDose, is a staff physician with Kosmix RightHealth. Dr. Chang practices Family Medicine at the University of California Davis Medical Center, where his medical interests include both pediatric and geriatric care, public health, gay and lesbian health, and sleep medicine. Dr. Chang trained at the Stanford University affiliated O'Connor Hospital, and was a research fellow at the National Institute of Health. He holds an M.D. from McGill University and a BA in Public Health from Johns Hopkins University.